In this interview, News-Medical talks to Sylvia Xie, product scientist at Sino Biological, about the ongoing emergence of transmembrane proteins as targets for therapeutic antibodies.
ABVC BioPharma to break ground in China, advances 20% stake in Zhonghui real estate
California-headquartered ABVC BioPharma is to expand its geographic reach through an acquisition agreement with Zhonghui United, with the biotech moving ahead with a 20% ownership